137 related articles for article (PubMed ID: 38581133)
1. Intradermal injection of Cutibacterium acnes and staphylococcus: A pustular acne-like murine model.
Zhou N; Sun Y; Ren X; Wang Y; Gao X; Li L; Ma Y; Hao Y; Wang Y
J Cosmet Dermatol; 2024 Jul; 23(7):2478-2489. PubMed ID: 38581133
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus epidermidis: A Potential New Player in the Physiopathology of Acne?
Claudel JP; Auffret N; Leccia MT; Poli F; Corvec S; Dréno B
Dermatology; 2019; 235(4):287-294. PubMed ID: 31112983
[TBL] [Abstract][Full Text] [Related]
4. Propionibacterium acnes-induced immunopathology correlates with health and disease association.
Kolar SL; Tsai CM; Torres J; Fan X; Li H; Liu GY
JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30843879
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.
Nakatsuji T; Kao MC; Fang JY; Zouboulis CC; Zhang L; Gallo RL; Huang CM
J Invest Dermatol; 2009 Oct; 129(10):2480-8. PubMed ID: 19387482
[TBL] [Abstract][Full Text] [Related]
6. PEG-8 Laurate Fermentation of
Marito S; Keshari S; Huang CM
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707723
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in understanding
Platsidaki E; Dessinioti C
F1000Res; 2018; 7():. PubMed ID: 30613388
[TBL] [Abstract][Full Text] [Related]
8. Culturable bacteria in the entire acne lesion and short-chain fatty acid metabolites of Cutibacterium acnes and Staphylococcus epidermidis isolates.
Huang TY; Jiang YE; Scott DA
Biochem Biophys Res Commun; 2022 Sep; 622():45-49. PubMed ID: 35843093
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Effect of a Newly Isolated Lytic Bacteriophage against Multi-Drug-Resistant
Lam HYP; Lai MJ; Chen TY; Wu WJ; Peng SY; Chang KC
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209998
[TBL] [Abstract][Full Text] [Related]
10. The Skin Microbiome: A New Actor in Inflammatory Acne.
Dréno B; Dagnelie MA; Khammari A; Corvec S
Am J Clin Dermatol; 2020 Sep; 21(Suppl 1):18-24. PubMed ID: 32910436
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial toner exhibits bactericidal effect against Cutibacterium acnes via keratin and sebum plug penetration.
Hamada S; Nakamura Y; Gomi M
J Microorg Control; 2024; 29(2):63-73. PubMed ID: 38880618
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of Cutibacterium (Propionibacterium) acnes clones from acne patients and healthy controls.
Lomholt HB; Scholz CFP; Brüggemann H; Tettelin H; Kilian M
Anaerobe; 2017 Oct; 47():57-63. PubMed ID: 28434779
[TBL] [Abstract][Full Text] [Related]
13. The increasing importance of the gut microbiome in acne vulgaris.
Siddiqui R; Makhlouf Z; Khan NA
Folia Microbiol (Praha); 2022 Dec; 67(6):825-835. PubMed ID: 35711021
[TBL] [Abstract][Full Text] [Related]
14. Acne fulminans and Cutibacterium acnes phylotypes.
Bocquet-Trémoureux S; Corvec S; Khammari A; Dagnelie MA; Boisrobert A; Dreno B
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):827-833. PubMed ID: 31715640
[TBL] [Abstract][Full Text] [Related]
15. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris.
O'Neill AM; Gallo RL
Microbiome; 2018 Oct; 6(1):177. PubMed ID: 30285861
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Topically Applied Selected Cutibacterium acnes Strains over Five Weeks in Patients with Acne Vulgaris: An Open-label, Pilot Study.
Karoglan A; Paetzold B; Pereira de Lima J; Brüggemann H; Tüting T; Schanze D; Güell M; Gollnick H
Acta Derm Venereol; 2019 Dec; 99(13):1253-1257. PubMed ID: 31573666
[TBL] [Abstract][Full Text] [Related]
17.
Hwang DH; Lee DY; Koh PO; Yang HR; Kang C; Kim E
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138302
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in understanding inflammatory acne: Deciphering the relationship between Cutibacterium acnes and Th17 inflammatory pathway.
Mias C; Mengeaud V; Bessou-Touya S; Duplan H
J Eur Acad Dermatol Venereol; 2023 Mar; 37 Suppl 2():3-11. PubMed ID: 36729400
[TBL] [Abstract][Full Text] [Related]
19. Electricity-producing Staphylococcus epidermidis counteracts Cutibacterium acnes.
Marito S; Keshari S; Traisaeng S; My DTT; Balasubramaniam A; Adi P; Hsieh MF; Herr DR; Huang CM
Sci Rep; 2021 Jun; 11(1):12001. PubMed ID: 34099817
[TBL] [Abstract][Full Text] [Related]
20. The Anticancer Agent 3,3'-Diindolylmethane Inhibits Multispecies Biofilm Formation by Acne-Causing Bacteria and Candida albicans.
Kim YG; Lee JH; Park S; Lee J
Microbiol Spectr; 2022 Feb; 10(1):e0205621. PubMed ID: 35107361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
